Product

General Info
Ireland
eculizumab
300 MG / 30ML (10MG/ML) – (single dose vial)
Hospital
Upload
Regulatory Approval
Country Product Indication Agency Indication Approval Date ODD Approval Date
France Soliris aHUS ANSM 4/30/2014 4/29/2009
France Soliris PNH ANSM 3/16/2007 8/20/2003
France Soliris gMG ANSM 10/23/2017 6/12/2014
France Soliris NMOSD ANSM 6/27/2019 6/24/2013
Prices
1,000 EUR
950 EUR
2019 Q1/2019 Q2/2019 Q3/2019 Q4/2019
100,000.00 EUR 1,000.00 EUR 1,020.00 EUR 980.00 EUR 1,000.00 EUR
2020 YTD Q1/2020 Q2/2020 Q3/2020 Q4/2020
16,000.00 EUR 1,000.00 EUR 1,020.00 EUR
1,200 EUR
700 EUR
SKU 1
Reimbursement Mechanism Channel Indication List Price Visible Net Price Non-Public Net Price In-Market Net Price Transfer Price Net Realized Price
Private Retail PNH 0.00 EUR 0.00 EUR 0.00 EUR 0.00 EUR 0.00 EUR 0.00 EUR
Private Retail AHUS 0.00 EUR 0.00 EUR 0.00 EUR 0.00 EUR 0.00 EUR 0.00 EUR
Public Hospital PNH 0.00 EUR 0.00 EUR 0.00 EUR 0.00 EUR 0.00 EUR 0.00 EUR
Public Hospital AHUS 0.00 EUR 0.00 EUR 0.00 EUR 0.00 EUR 0.00 EUR 0.00 EUR
SKU 2
Reimbursement Mechanism Channel Indication List Price Visible Net Price Non-Public Net Price In-Market Net Price Transfer Price Net Realized Price
Private Retail PNH 0.00 EUR 0.00 EUR 0.00 EUR 0.00 EUR 0.00 EUR 0.00 EUR
Private Retail AHUS 0.00 EUR 0.00 EUR 0.00 EUR 0.00 EUR 0.00 EUR 0.00 EUR
Public Hospital PNH 0.00 EUR 0.00 EUR 0.00 EUR 0.00 EUR 0.00 EUR 0.00 EUR
Public Hospital AHUS 0.00 EUR 0.00 EUR 0.00 EUR 0.00 EUR 0.00 EUR 0.00 EUR
PNH
Access Details
VAL
VAL
VAL
VAL
VAL
VAL
VAL
VAL
VAL
VAL
VAL
HTA Assessment
VAL
VAL
VAL
VAL
VAL
VAL
Price Negotiation
VAL
VAL
VAL
VAL
VAL
Managed Entry Agreements
VAL : DETAILS VAL
VAL : DETAILS VAL
VAL : DETAILS VAL
VAL : DETAILS VAL
VAL : DETAILS VAL
VAL : DETAILS VAL
VAL : DETAILS VAL
VAL : DETAILS VAL
VAL : DETAILS VAL
VAL : DETAILS VAL
VAL : DETAILS VAL
Further Plans
VAL
VAL
VAL
VAL
VAL
VAL
VAL
Edit
Figures shown are for the whole of the UK (Last updated YYYY-MM-DD HH:MM)
Ultomiris: Total
  2020 Total Q1/2021 Q2/2021 Q3/2021 Q4/2021 2021 Total
  Actuals Actuals AOP Actuals AOP Actuals AOP Actuals AOP Actuals AOP
Revenue: 99,999,999.00 USD
1 Vial 300mg / 30ml Volume (in vials): 1000
1 Vial 1100mg / 11ml Volume (in vials): 1000
1 Vial 300mg / 3ml Volume (in vials): 1000
Ultomiris: PNH
  2020 Total Q1/2021 Q2/2021 Q3/2021 Q4/2021 2021 Total
  Actuals Actuals AOP Actuals AOP Actuals AOP Actuals AOP Actuals AOP
Revenue: 99,999,999.00 USD
1 Vial 300mg / 30ml Volume (in vials): 1000
1 Vial 1100mg / 11ml Volume (in vials): 1000
1 Vial 300mg / 3ml Volume (in vials): 1000
Ultomiris 1 Vial 300 mg / 30 ml
  2020 Total Q1/2021 Q2/2021 Q3/2021 Q4/2021 2021 Total
  Actuals Actuals AOP Actuals AOP Actuals AOP Actuals AOP Actuals AOP
Revenue: 99,999,999.00 USD
Volume (in vials): 1000
Net Realized Price (per vial): 99,999.00 USD
Ultomiris 1 Vial 1100 mg / 11 ml
  2020 Total Q1/2021 Q2/2021 Q3/2021 Q4/2021 2021 Total
  Actuals Actuals AOP Actuals AOP Actuals AOP Actuals AOP Actuals AOP
Revenue: 99,999,999.00 USD
Volume (in vials): 1000
Net Realized Price (per vial): 99,999.00 USD
Ultomiris 1 Vial 300 mg / 3 ml
  2020 Total Q1/2021 Q2/2021 Q3/2021 Q4/2021 2021 Total
  Actuals Actuals AOP Actuals AOP Actuals AOP Actuals AOP Actuals AOP
Revenue: 99,999,999.00 USD
Volume (in vials): 1000
Net Realized Price (per vial): 99,999.00 USD
Ultomiris PNH: Ultomiris 1 Vial 300 mg / 30 ml
  2020 Total Q1/2021 Q2/2021 Q3/2021 Q4/2021 2021 Total
  Actuals Actuals AOP Actuals AOP Actuals AOP Actuals AOP Actuals AOP
Revenue: 99,999,999.00 USD
Volume (in vials): 1000
Net Realized Price (per vial): 99,999.00 USD
Ultomiris PNH: Ultomiris 1 Vial 1100 mg / 11 ml
  2020 Total Q1/2021 Q2/2021 Q3/2021 Q4/2021 2021 Total
  Actuals Actuals AOP Actuals AOP Actuals AOP Actuals AOP Actuals AOP
Revenue: 99,999,999.00 USD
Volume (in vials): 1000
Net Realized Price (per vial): 99,999.00 USD
Ultomiris PNH: Ultomiris 1 Vial 300 mg / 3 ml
  2020 Total Q1/2021 Q2/2021 Q3/2021 Q4/2021 2021 Total
  Actuals Actuals AOP Actuals AOP Actuals AOP Actuals AOP Actuals AOP
Revenue: 99,999,999.00 USD
Volume (in vials): 1000
Net Realized Price (per vial): 99,999.00 USD
Ultomiris aHUS: Ultomiris 1 Vial 300 mg / 30 ml
  2020 Total Q1/2021 Q2/2021 Q3/2021 Q4/2021 2021 Total
  Actuals Actuals AOP Actuals AOP Actuals AOP Actuals AOP Actuals AOP
Revenue: 99,999,999.00 USD
Volume (in vials): 1000
Net Realized Price (per vial): 99,999.00 USD
Ultomiris aHUS: Ultomiris 1 Vial 1100 mg / 11 ml
  2020 Total Q1/2021 Q2/2021 Q3/2021 Q4/2021 2021 Total
  Actuals Actuals AOP Actuals AOP Actuals AOP Actuals AOP Actuals AOP
Revenue: 99,999,999.00 USD
Volume (in vials): 1000
Net Realized Price (per vial): 99,999.00 USD
Ultomiris aHUS: Ultomiris 1 Vial 300 mg / 3 ml
  2020 Total Q1/2021 Q2/2021 Q3/2021 Q4/2021 2021 Total
  Actuals Actuals AOP Actuals AOP Actuals AOP Actuals AOP Actuals AOP
Revenue: 99,999,999.00 USD
Volume (in vials): 1000
Net Realized Price (per vial): 99,999.00 USD
Soliris: Total
  2020 Total Q1/2021 Q2/2021 Q3/2021 Q4/2021 2021 Total
  Actuals Actuals AOP Actuals AOP Actuals AOP Actuals AOP Actuals AOP
Revenue: 99,999,999.00 USD
Volume (in vials): 1000
Net Realized Price (per vial): 99,999.00 USD
Soliris: PNH
  2020 Total Q1/2021 Q2/2021 Q3/2021 Q4/2021 2021 Total
  Actuals Actuals AOP Actuals AOP Actuals AOP Actuals AOP Actuals AOP
Revenue: 99,999,999.00 USD
Volume (in vials): 1000
Net Realized Price (per vial): 99,999.00 USD